Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

H Fleisch, R Graham, G Russell, MD Francis - Science, 1969 - science.org
Two diphosphonates containing the PCP bond, Cl 2 C(PO 3 HNa) 2 and H 2 C(PO 3 HNa) 2
retard the rate of dissolution of apatite crystals in vitro. They inhibit bone resorption induced …

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo

MD Francis, R Graham, G Russell, H Fleisch - Science, 1969 - science.org
Two diphosphonates containing the PCP bond, CH 3 C(OH)(PO 3 HNa) 2 and H 2 C(PO 3
HNa) 2 , inhibit the crystallization of calcium phosphate in vitro and prevent aortic calcification …

The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates

MD Francis - Calcified Tissue Research, 1969 - Springer
The formation of crystalline calcium hydroxyapatite from solutions of calcium and phosphate
ions and the inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and …

Hydroxyapatite formation from a hydrated calcium monohydrogen phosphate precursor

MD Francis, NC Webb - Calcified Tissue Research, 1970 - Springer
Hydrated calcium monohydrogen phosphate is proposed as the logical precursor in the
formation of hydroxyapatite and a unifying theory for the formation of low calcium, or defect …

[PDF][PDF] Correlation of neoplasms with incidence and localization of skeletal metastases: an analysis of 1,355 diphosphonate bone scans

AJ Tofe, MD Francis, WJ Harvey - Journal of Nuclear Medicine, 1975 - Soc Nuclear Med
MATERIALSANDMETHODS A group of 1,891 patients from 16 medical insti tutions was
scanned during the clinical trials of the OOmTcSn. EHDP skeletal-imaging agent, Osteoscan®. …

Bone scanning: radionuclidic reaction mechanisms

AG Jones, MD Francis, MA Davis - Seminars in nuclear medicine, 1976 - Elsevier
One of the major successes of nuclear medicine in recent years has been the clinical utility
of the 99m Tc-Tabeled bone-imaging agents. This article is concerned with the evidence …

Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues

…, A Mukherjee, RW Parkey, MD Francis… - The Journal of …, 1977 - Am Soc Clin Investig
This study was performed to elucidate the localization at the cellular level of technetium-99m
phosphorus ( 99m Tc-P) radiopharmaceuticals in acute myocardial infarcts and the …

Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).

MD Francis, DL Ferguson, AJ Tofe… - Journal of Nuclear …, 1980 - europepmc.org
We have investigated the in vitro adsorption of three C-14-labeled diphosphonates on
calcium phosphate. The three are 1-hydroxy [1-14C] ethylidene diphosphonate (C-14 HEDP),[14C…

Retention of etidronate in human, dog, and rat

GB Kasting, MD Francis - Journal of Bone and Mineral …, 1992 - Wiley Online Library
The retention of radioactivity in human, rat, and dog following a single injected dose of
radiolabeled etidronate disodium (EHDP) is shown to follow power‐law decay curves with similar …

Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.

JA Bevan, AJ Tofe, JJ Benedict, MD Francis… - Journal of nuclear …, 1980 - europepmc.org
Technetium-99m hydroxymethylene diphosphonate (Tc-99M HMDP) is a new diphosphonate
skeletal imaging agent. Animal studies show that Tc-99m HMDP has a higher uptake on …